Error message

The page you requested does not exist. For your convenience, a search was performed using the query events thu 17 dec 1000 systemic anti cancer therapy these talks are aimed masters first year phd.

Search results

  1. Dr Catherine Lindon

    ... role of substrate proteolysis in the precisely coordinated events giving rise to two daughter cells at the end of mitosis. The Aurora ...

  2. Dr Athena Matakidou

    ... modify the mouse renal apithelium and replicate the genetic events observed in human renal cell carcinoma. The development of reproducible ...

  3. Dr Mariann Bienz

    ... cell compartment. Our aim is to understand the molecular events underlying Wnt signal transduction. We focus on positively-acting ...

  4. Dr Dario Bressan

    ... for the spatial and temporal control of biological events in vivo. Specifically, I am using photochemically caged ligands and ...

  5. Dr Frank McCaughan

    My research is focused on understanding the early driver events that are critical to the development of squamous lung cancer (SQC) and ...

  6. Professor Gillian Murphy

    ... by trafficking which allows specific localisation in events such as cell invasion. The identification of the importance of specific ...

  7. Dr James Nathan

    Cellular mechanisms of oxygen and metabolite sensing: ...

  8. Dr James Rudd

    ... arteries as a predictor of plaque rupture and clinical events. Additionally, I use non-invasive imaging methods such as PET, MRI and ...

  9. Ms Paola Marco

    ... The inhibitor can be washed out, allowing us to study events in a more flexible way. I will introduce these mutants in RPE cells to ...

  10. Dr Marisa Segal

    ... morphogenesis in S. cerevisiae we have focused on the events that determine SPB asymmetry or spindle polarity, i.e. the mechanisms ...

  11. Dr David Gilligan

    David Gilligan is a Consultant Clinical Oncologist at Addenbrooke's and Papworth Hospitals in Cambridge. He is the Clinical Lead for Acute Oncology at Addenbrooke's. He trained in pre clinical medicine at the University of Edinburgh and clinical...

  12. Mr David Thurtle

    Radiological assessment of prostatic osseous metastases. Robotic-assisted laparoscopic prostatectomy. Early detection of prostate cancer. Risk Prediction in prostate cancer

  13. Professor David Glover

    Our laboratory studies the regulation of progression through mitosis and meiosis in animal cells. The high degree of evolutionary conservation of these regulatory mechanisms means that findings in model organisms are readily applicable to human cells....

  14. Dr Roisin Owens

    Our group works on integrating biological models with electronic devices to generate systems that can be predictive of real biological systems, for drug discovery and therapeutics. We combine expertise in a wide range of disciplines including...

  15. Mr Thierry Lefebvre

    Radiotherapy is often prescribed in oncology clinics to treat solid tumours and to limit the development and the propagation of cancer cells. The lack of oxygenation seen in some tumour regions under chaotic and unrestricted cellular growth constitute a...

  16. Professor Walid Khaled

    My laboratory works on defining the early cellular and molecular events that drive tumour initiation and development. In particular, we focus on how the cell of origin affects the differentiation trajectory of nascent tumour cells and dictates changes...

  17. Mr Adam Palmer

  18. Mrs Angela Godoy

  19. Dr Adrian Kelly

    Biology of MHC class I and class II antigen processing and presentation pathways.

  20. Professor Tony Green

    Tony Green is Professor of Haemato-oncology in the University of Cambridge and honorary Consultant Haematologist at Addenbrookes Hospital. He was appointed Head of the University Department of Haematology (2000-2020), and in 2016 was appointed Director...

  21. Dr Alex Samoshkin

    I have been a Translational Technology Manager in the University of Cambridge since 2017. My primary role is to connect researchers in technology/physical sciences with clinicians and academics to develop new collaborative translational projects. I...

  22. Dr Chiwen Chang

    1. Interaction between NK cells and HLA Class I antigen during immune response. 2. Immunotherapy for cancers and autoimmune diseases.

  23. Dr Christopher Shepherd

  24. Professor Charlotte Coles

    Charlotte Coles is Professor of Breast Cancer Clinical Oncology and NIHR Research Professor at the CRUK Cambridge Centre. Her research aims are to provide breast cancer patients with the best chance of cure with least side effects by personalising...

  25. Professor David Rubinsztein

  26. Dr Elizabeth Soilleux

  27. Dr Adrien Hallou

    Initially trained as a physicist and a chemist at the Ecole Normale Supérieure (Paris, France), I developed my interest for quantitative approaches of biological systems during my MPhil and PhD in Biophysics at the University of Cambridge. I am now a...

  28. Professor Andrew Flewitt

    I work in large area electronics and MEMS devices, with a particular focus on acoustic wave devices using thin film piezoelectrics. There are two applications of these. Surface acoustic wave (SAW) devices can be used to make microfluidic pumps without...

  29. Dr Andrew Bannister

    I have spent the last three decades generally messing around with chromatin with a special focus on histones and their modifications. My research has focused on identifying novel histone modifications together with characterization of the enzymes ...

  30. Dr Simon Cook

    In terms of basic science we are interested in how protein kinase and lipid signalling pathways control cell fate decisions such as proliferation versus differentiation and survival versus death. However, these pathways are frequently de-regulated in...

  31. Dr David Adams

    David performs forward genetic screens to uncover cancer genes and pathways and leads a programme to decode the genomes of several mouse strains. He also leads the Mouse Genomes Project and the Mouse Genetics Project. The Mouse Genomes Project is...

  32. Professor Eric Miska

    Our main goal is to understand how cells interpret genetic and epigenetic information as well as environmental cues to determine their correct cell fate, i.e. to make the decision to divide, die or differentiate. The recent discovery of a large...

  33. Professor Evis Sala

    Now based in Rome, my research in Cambridge focused on integrated diagnostics, through the clinical development and validation of functional imaging biomarkers to rapidly evaluate treatment response using physiologic and metabolic tumour habitat imaging...

  34. Dr Helen Morris

    In the Primary Care Unit I've managed and collaborated on a number of randomised controlled trials and other well-designed studies in the field of cancer and genetics in a primary care setting: 1) The GRAIDS (Genetic Risk Assessment on the Internet and...

  35. Professor Heike Laman

    F-box proteins (FBPs) are the substrate-recruiting subunits of SCF (Skp1-cullin1-FBP)-type E3 ubiquitin ligases, but ubiquitinated substrates have been identified for only a few of the sixty-nine FBPs identified in humans. The major aim of my laboratory...

  36. Professor Eamonn Maher

    Eamonn Maher is Professor of Medical Genetics and Genomic Medicine and Head of the Department of Medical Genetics. Prior to taking up this post in 2013 he was Professor of Medical Genetics and Academic Lead for the Centre for Rare Diseases and...

  37. Professor Ferdia Gallagher

    Dr Ferdia Gallagher studied medicine as an undergraduate at the University of Cambridge before completing his clinical studies at the University of Oxford. He trained as a radiologist at Addenbrooke?s Hospital in Cambridge. In 2005, he was awarded a...

  38. Dr Helen Davies

  39. Dr Kerstin Meyer

    Genetic Susceptibility to Breast Cancer 1. Functional analysis of predisposition loci: My experiments are aimed at understanding the mechanisms by which breast cancer risk loci contribute to disease risk. This has involved the identification of...

  40. Professor Matthew Allen

    My laboratory is interested in preclinical modelling of musculoskeletal cancer, with a particular emphasis on paediatric cancers (such as osteosarcoma, rhabdomyosarcoma and Ewings sarcoma) and adult cancers that spread to bone (such as breast, prostate,...

  41. Professor Steven Ley

  42. Dr Paul Lyons

    ... to the clinical management of autoimmune diseases such as systemic lupus erythematosus and small vessel vasculitis. This approach will ...

  43. Professor Randall Johnson

    ... homeostasis, including pulmonary vascular tension and even systemic blood pressure.  We have found that this control is highly related to ...

  44. Dr Trevor Littlewood

    The use of classical, germ-line genetics to define gene function in vertebrates is severely limited by embryonic lethality, developmental compensation and adaptive functional degeneracy, all of which obscure the roles played by genes in adult tissues...

  45. Dr Will Ince

    ... prostate and recurrent/metastatic head and neck cancer with systemic treatments  Improving approaches to personalised radiotherapy in ...

  46. Dr Adeeba Fathima Valiya Thodiyil

    Single cell/Tissue imaging, quantitative microscopy, image analysis 

  47. Dr Antony Rix

    Co-founded by Prof Evis Sala and Dr Antony Rix, Lucida Medical is a spin-out from the University of Cambridge Department of Radiology and Cambridge University Hospitals. The company develops AI-based software to help automate the analysis of...

  48. Professor Anthony Davenport

    Our research group focuses on understanding the role of G-protein-coupled receptors (GPCRs, targets for about ~50% of current drugs) together with their transmitters in humans. We use in vitro pharmacology and in vivo imaging using positron emission...

  49. Professor Kevin Brindle

    ... methods for detecting and predicting responses to an anti-vascular drug and for detecting early tumour responses to immunotherapy. ...

  50. Dr Bristi Basu

    I co-lead the Cambridge Experimental Cancer Medicine Centre with Prof Duncan Jodrell and the CRUK Cambridge Centre Pancreatic Cancer Programme with Dr Giulia Biffi. Other roles include Capacity Building leadership team within the Cambridge NIHR...

  51. Dr Cedric Ghevaert

    Cedric Gevaert graduated from the medical school of the University Libre de Bruxelles in 1997 and subsequently became a fellow of the Royal College of Physicians, London (2000). He specialised in Haematology and became a fellow of the Royal College of...

  52. Dr Ali Amin Al Olama

    ... has focused on discovery of genetic risk factors of prostate cancer through genome-wide association studies and fine-mapping. I am a core member of an international consortium PRACTICAL (Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the ...

  53. Dr Andreas Bender

    ... large amounts of chemical or biological data related to cancer drug discovery you are very welcome to contact me to see in which way I ...

  54. Dr Alejandra Bruna

    ... aimed to study the effects of the TGF-beta pathway in breast cancer stem cell (BCSC) regulation. To define a role of the TGF-beta pathway in ... of human BCSCs, we have analyzed a panel of breast cancer cell lines that represent the molecular heterogeneity present in primary ...

  55. Professor Antonis Antoniou

    ... component; - the identification and characterisation of cancer risks for genetically susceptible individuals, such as those carrying ...

  56. Dr Alison Dunning

    Work in the Centre for Cancer Genetic Epidemiology "wet lab" involves running very high throughput ... (NGS) studies. We search for genetic risk factors for both cancer susceptibility and treatment-response. In this we collaborate closely ... consortia for breast, ovarian, endometrial and prostate cancer association studies: BCAC http://bcac.ccge.medschl.cam.ac.uk, CIMBA ...

  57. Dr Ashray Gunjur

    ... broadly interested in immuno-oncology and the link between cancer and the gut microbiome, and am undertaking a PhD supervised by Dr David ... between gut microbiota and outcomes in patients with rare cancer types. ...

  58. Dr Ahsan MEMON

    ... this holographic system was deployed to the study of cancer and stem cell shape regulation and the role of effective membrane ...

  59. Dr Aisling Redmond

    ... She completed postdoctoral fellowships in the breast cancer field at the Royal College of Surgeons in Ireland and Cancer Research UK Cambridge Institute (with Professor Jason Carroll), ...

  60. Professor Alan Warren

    ... how defects in this process cause bone marrow failure and cancer predisposition. Assembly of the two subunits of the ribosome, containing ... it is also important for oncogenesis: a novel class of human cancer predisposition disorder has recently emerged that is caused by mutations ...

  61. Dr Andrew Gee

    Since 1995, I have been working on technical aspects of clinical ultrasonic imaging, with particular emphasis on three-dimensional imaging and elastography (stiffness imaging). Along with Richard Prager and Graham Treece, I lead the Medical Imaging...

  62. Dr Andre Neves

    ... cancer diagnosis and for better assessing response to cancer therapy. Currently, I'm planning a first-in-human clinical trial of a novel ...

  63. Dr Richard Benson

    Interests based around improving radiotherapy and chemoradiotherapy in head and neck and urological cancers, develpoing technical radiotherapy and evaluating treatment related toxicity.

  64. Professor Bertie Gottgens

    ... blood stem/progenitor cell populations used in cell and gene therapy protocols. ...

  65. Dr Camilo Colaco

    Developing cancer therapy as opposed to research. Autologous tumour-dendritic cell fusion hybrids ...

  66. Dr Camilo Colaco

  67. Dr Christopher Jones

    My research focuses on improving the radiation response and post-radiation monitoring of oesophageal cancers, with a particular focus on oesophageal adenocarcinoma. I am also interested in the study of radiotherapy-related genomic evolution.

  68. Dr Claire Connell

    Pancreatic cancer and immunotherapy

  69. Dr Adrian Ionescu

    ... up a strong track record with international recognition in these research areas, with 50 publications and two books to date. With some of these publications I have helped shape the new interdisciplinary field of ...

  70. Dr Alasdair Russell

    ... model systems in a pre-clinical setting. Further, we use these novel models in a range of pre-clinical trials to advance our ...

  71. Mr Angelos Kolias

    ... and evaluation of PET-guided surgery for pituitary adenomas. These are collaborative projects with Mr Richard Mannion (Clinical Lead for ...

  72. Professor Anna Philpott

    ... a disease of differentiation. Ultimately, our studies on these fundamental mechanisms that co-ordinate proliferation and differentiation ...

  73. Dr Alex Cagan

    ... our own bodies are constantly acquiring mutations. Some of these mutations may influence cellular phenotypes, such as growth, resulting in ... Over time our bodies become a patchwork of clones. These processes drive cancer progression and may contribute to ageing.  Due to ...

  74. Professor Ben Simons

    ... epidermal maintenance in mouse. Currently, we are extending these ideas to explore cell fate in human epidermis addressing both normal and malignant tissue. These investigations are pursued in close collaboration with experimentalists ...

  75. Dr Basma Greef

    ... of hypoxia response pathways in renal cancer and how these can be harnessed to develop new treatments. My other interests include ...

  76. Professor Adrian Liston

    We are focussed on understanding the biology of regulatory T cells within the ...

  77. Miss Amara Cañizares

  78. Dr Fazlur Rahman Talukdar

    ... (IARC-WHO), France, in 2015. During this tenure, my research aimed to identify DNA methylome alterations linked to esophageal cancer within ...

  79. Dr Misha Kapushesky

    ... a universal ecosystem for bioinformatics development, aimed to reduce the chaotic clutter of inefficiency and incompatibility in ...

  80. Dr Nicholas Walton

    ... currently aiding in their search for new techniques aimed at the treatment of breast cancer. ...

  81. Professor Rahul Roychoudhuri

    ... providing targets for development of new therapies aimed at reversing dysfunctional immune responses in cancer. ...

  82. Dr Sujath Abbas

    ... I developed a cost-effective DNA sequencing method (mutREAD) aimed for screening of mutational signatures using FFPE DNA, envisioning its ...

  83. Mr liam masterson

  84. Professor Vincent Gnanapragasam

    ... Cambridge University Hospitals and ARU to establish a Masters in Urology programme for early stage clinicians aspiring to a career in ...

  85. Professor Tim Eisen

    ... where I am currently responsible for oncology trials from first in man to Phase II. ...

  86. Dr Elisa Laurenti

    ... As perturbation of HSC regulatory networks drives the first steps of leukaemia, knowledge of HSC specific molecular responses will ...

  87. Dr Kelly Holmes

    ... CRUK Cambridge Centre Imaging Programme Manager. Kelly has a first class degree in Biochemistry with a year in industry. She completed her ...

  88. Professor Duncan Jodrell

    ... therapies and novel therapeutic combinations, including first into man (phase I) and associated studies.  My research goal is to ...

  89. Dr Laura Blackburn

    ... research and held a workshop on the implementation of the first ctDNA testing services in the NHS, which were facilitating treatment ...

  90. Dr Lori Passmore

    ... of translation to control gene expression, and is the first step in mRNA turnover. The major deadenylase activities are found within ...

  91. Dr Daniel Hodson

    Pathogenesis of Germinal Centre Derived B Cell Lymphomas. Many of the commonest human lymphomas (including follicular, diffuse large B cell and Burkitt lymphomas) develop from a specific stage of B lymphocyte differentiation termed the Germinal Centre. ...

  92. Dr Joanna Baxter

    The Cambridge Blood and Stem Cell Biobank is a facility of over 6000 viable and nucleic acid samples, the majority from patients with haematological malignancy and clonal blood cell disorders; and the remainder, around 20%, from normal individuals,...

  93. Mrs Eva Serrao

    Despite medical advances, pancreatic cancer still has a 5-year survival rate of less than 6%. The ideal way to improve this is to ...

  94. Dr Hayley Woffendin

    After many years working as a postdoctoral research scientist (Molecular Biologist) within the University and Wellcome Trust Sanger Institute, I have been Scientific Administrator and Graduate Student Administrator with the Department of Oncology Since...

  95. Dr Hannah Harrison

    Since moving into public health research around 5 years, Hannah has been involved in projects investigating risk-stratification for kidney cancer screening and follow-up. Her most rencet project, funded by CRUK, is investigating multifactorial models...

  96. Dr Amos Burke

    ... and currently co-supervises a Clinical and a basic science PhD student. At a national level Dr Burke is the National Institute for Health ...

  97. Miss Annalisa Occhipinti

    I am a Mathematician and I am doing a PhD in bioinformatics at the University if Cambridge. I am currently working on ...

  98. Ms Ceilidh Welsh

    I am a PhD student working with  Cancer Research UK RadNet Cambridge Radiation ...

  99. Dr Danish Mazhar

    ... and Charing Cross Hospitals in London. He was awarded a PhD by Imperial College London for his research in Prostate Cancer. He has also ...

  100. Dr Emmanuel Huguet

    ... undergraduate medical students. He subsequently undertook a PhD in cancer molecular biology at Oxford University in the laboratories of the ...

Pages